Ute Schwiderski

905 total citations
13 papers, 737 citations indexed

About

Ute Schwiderski is a scholar working on Pharmacology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ute Schwiderski has authored 13 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ute Schwiderski's work include Treatment of Major Depression (6 papers), Acute Ischemic Stroke Management (4 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). Ute Schwiderski is often cited by papers focused on Treatment of Major Depression (6 papers), Acute Ischemic Stroke Management (4 papers) and Cerebrovascular and Carotid Artery Diseases (4 papers). Ute Schwiderski collaborates with scholars based in United States and Germany. Ute Schwiderski's co-authors include LuAnn Sabounjian, Bobby W. Sandage, Lawrence R. Wechsler, Wayne M. Clark, Norman R. Zinner, Annabel Nixon, David Staskin, Shoshana Colman, Majaz Moonis and Kevin Kane and has published in prestigious journals such as Neurology, Stroke and Annals of Neurology.

In The Last Decade

Ute Schwiderski

13 papers receiving 697 citations

Peers

Ute Schwiderski

EPIDE

NEURO

RHEUM

UROLO

PRM

Bobby W. Sandage United States

Yi Ju China

Sher-Wei Lim Taiwan

Howard Marshall United Kingdom

J P Frankel United States

Oscar Contreras Ortiz Argentina

Akito Inadome Japan

Edoardo Ostardo Italy

Licia Denti Italy

Kenneth Powers United States

Bobby W. Sandage United States

Ute Schwiderski

379 ×0.9

EPIDE

300 ×1.3

NEURO

277 ×1.6

RHEUM

285 ×1.7

UROLO

82 ×0.6

PRM

Citations per year, relative to Ute Schwiderski Ute Schwiderski (= 1×) peers Bobby W. Sandage

Countries citing papers authored by Ute Schwiderski

Since Specialization

Citations

This map shows the geographic impact of Ute Schwiderski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Schwiderski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Schwiderski more than expected).

Fields of papers citing papers by Ute Schwiderski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Schwiderski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Schwiderski. The network helps show where Ute Schwiderski may publish in the future.

Co-authorship network of co-authors of Ute Schwiderski

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Schwiderski. A scholar is included among the top collaborators of Ute Schwiderski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Schwiderski. Ute Schwiderski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Harnett, Mark, et al.. (2012). Study of the Population Pharmacokinetic Characteristics of Once-Daily Trospium Chloride 60 mg Extended-Release Capsules in Patients with Overactive Bladder and in Healthy Subjects. Clinical Drug Investigation. 33(2). 133–141. 3 indexed citations

2.

Sandage, Bobby W., et al.. (2009). Pharmacokinetics of Once‐Daily Trospium Chloride 60 mg Extended Release and Twice‐Daily Trospium Chloride 20 mg in Healthy Adults. The Journal of Clinical Pharmacology. 50(2). 143–150. 11 indexed citations

3.

Nixon, Annabel, Shoshana Colman, LuAnn Sabounjian, et al.. (2005). A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS. The Journal of Urology. 174(2). 604–607. 169 indexed citations

4.

Moonis, Majaz, Kevin Kane, Ute Schwiderski, Bobby W. Sandage, & Marc Fisher. (2005). HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome. Stroke. 36(6). 1298–1300. 104 indexed citations

5.

Clark, Wayne M., Lawrence R. Wechsler, LuAnn Sabounjian, & Ute Schwiderski. (2001). A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology. 57(9). 1595–1602. 160 indexed citations

6.

Warach, S., L. Creed Pettigrew, John F. Dashe, et al.. (2000). Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging. Annals of Neurology. 48(5). 713–722. 7 indexed citations

7.

Warach, S., L. Creed Pettigrew, John F. Dashe, et al.. (2000). Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging. Annals of Neurology. 48(5). 713–722. 182 indexed citations

8.

Cohn, Cal K., et al.. (1996). Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.. PubMed. 57 Suppl 2. 15–8. 60 indexed citations

9.

Vogel, Gerald W., et al.. (1994). Effects Of Nefazodone On Sleep Architecture And Daytime Alertness. Neuropsychopharmacology. 11(4). 288–288. 1 indexed citations

10.

Gammans, Richard E., et al.. (1992). NEFAZODONE EFFICACY IN SEVERE DEPRESSION. Clinical Neuropharmacology. 15. 332B–332B. 1 indexed citations

11.

Mendels, J., Fred Reimherr, Daniel G. Roberts, et al.. (1991). A double-blind comparison of high-dose nefazodone, low-dose nefazodone, and placebo in the treatment of depressed outpatients. European Neuropsychopharmacology. 1(3). 451–452. 1 indexed citations

12.

Schwiderski, Ute, et al.. (1990). Symptom Comorbidity in Anxiety and Depressive Disorders. Journal of Clinical Psychopharmacology. 10(Supplement). 52S–60S. 13 indexed citations

13.

Roberts, D L, et al.. (1990). Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.. PubMed. 26(1). 147–50. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact